Hematologic Response and Frequency of Side Effects in Chronic Myeloid Leukemia Patients Treated with Imatinib (GLIVEC): A South-East Asian Experience

Autor: Aslam, Hafiz M *, 1, Shumaila, Iqbal M *, 2, Merchant, Ambreen A *, 3, Muhammad, Mariam G *, 4, Yasir, Javeria *, 4, Faizee, Faizan A *, 4, Qadir, Madiha A *, 4
Zdroj: In Blood 8 December 2017 130 Supplement 1:5257-5257
Databáze: ScienceDirect